Rapimig orally dispersible tablets contain the active ingredient zolmitriptan 2.5mg, designed for the acute care for migraine attacks. Each pack contains 2 tablets in a convenient blister format. Manufactured by Actavis Ltd., Malta, under the TEVA brand, these tablets dissolve quickly in the mouth without the need for water, offering ease of use during a migraine episode.
Zolmitriptan belongs to the triptan class of medications, which work by targeting serotonin receptors to help manage migraine symptoms. The orally dispersible form is particularly suitable for individuals who may experience nausea or difficulty swallowing during an attack. Always follow the usage instructions provided by your healthcare professional.
How do I take Rapimig tablets?
Place the tablet on your tongue, where it will dissolve quickly. No water is needed
What is the active ingredient?
Each tablet contains 2.5mg of zolmitriptan
How many tablets are in a pack?
This pack contains 2 tablets